IMMUNEEL THERAPEUTICS
Immuneel Therapeutics Pvt Ltd is a pioneering startup company leading the charge in cell therapy and personalized immunotherapy for patients
IMMUNEEL THERAPEUTICS
Industry:
Biotechnology Health Care Product Research
Founded:
2018-01-01
Address:
Bengaluru, Karnataka, India
Country:
India
Website Url:
http://www.immuneel.com
Total Employee:
11+
Status:
Active
Total Funding:
14.85 M USD
Investors List
True North
True North investment in Series A - Immuneel Therapeutics
F-Prime Capital
F-Prime Capital investment in Series A - Immuneel Therapeutics
Eight Roads Ventures
Eight Roads Ventures investment in Series A - Immuneel Therapeutics
F-Prime Capital
F-Prime Capital investment in Seed Round - Immuneel Therapeutics
Eight Roads Ventures
Eight Roads Ventures investment in Seed Round - Immuneel Therapeutics
Official Site Inspections
http://www.immuneel.com Semrush global rank: 4.54 M Semrush visits lastest month: 2.31 K
- Host name: 45.113.122.143
- IP address: 45.113.122.143
- Location: India
- Latitude: 20.0063
- Longitude: 77.006
- Timezone: Asia/Kolkata
More informations about "Immuneel Therapeutics"
Immuneel Therapeutics Private Limited
Immuneel is bringing breakthrough cancer treatment to India. Affordably. Cell, gene and immunotherapy are at the frontier of cancer treatment, offering real hope to millions. In the few …See details»
Company - Immuneel Therapeutics Private Limited
Immuneel is an Indian company with a global outlook. Our ambition and effort is to make cell therapies affordable in India, and has the potential to enable access globally. Delivering on our …See details»
Immuneel Therapeutics - Crunchbase Company Profile …
Immuneel Therapeutics provides pioneering cell and gene therapies for cancer treatment. They develop CAR-T cell therapies from patients' blood cells by genetically modifying healthy immune cells to target malignant cells, giving …See details»
Immuneel Company Profile 2024: Valuation, Funding & Investors
Immuneel General Information Description. Developer of a cell therapy intended to provide cell and gene therapies for cancer treatment. The company develops CAR-T cell therapies …See details»
Immuneel Therapeutics Pvt. Ltd. | LinkedIn
Immuneel Therapeutics Welcomes Amit Mookim as CEO We are excited to announce the appointment of Mr. Amit Mookim as the new Chief Executive Officer of Immuneel …See details»
Immuneel Therapeutics Pvt Ltd. - Drug pipelines, Patents, Clinical ...
Explore Immuneel Therapeutics Pvt Ltd. with its drug pipeline, therapeutic area, technology platform, 2 clinical trials, 5 news, Disease Domain:Hemic and Lymphatic Diseases, …See details»
Investors & Media - Immuneel Therapeutics Private Limited
A bold initiative to disrupt the landscape of cancer treatment in India, Immuneel is a privately-owned Indian clinical stage startup company established in 2018, and seed-funded through …See details»
Immuneel Therapeutics - Funding, Financials, Valuation & Investors
Jun 21, 2022 Immuneel Therapeutics is a biotechnology startup that focuses on cell therapy and personalized immunotherapy for patients. Search Crunchbase. Start Free Trial . ... How much …See details»
Press Release - Hospital ClÃnic Barcelona
Immuneel is a pioneering start-up company leading the change in cell & gene therapy & personalized immunotherapy for patients in India. Headquartered in Bangalore, India – a …See details»
Immuneel Therapeutics - Updates, News, Events, Signals & Triggers
Organization. Immuneel Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Growth Insight Details. Powered by AI . ...See details»
Immuneel Therapeutics raises $15 million in funding - The …
Jun 21, 2022 Immuneel Therapeutics, a biotech startup engaged in developing cell and gene therapies, has raised $15 million in Series A financing round co-led by Eight Roads Ventures, …See details»
Cut-price CAR-T cell therapies top India’s biotech agenda
Dec 3, 2019 Immuneel has already raised 1 billion rupees ($15 million) from investors who include India’s major hospital chains and pharma companies, as well as venture capitalists …See details»
Biotech startup Immuneel Therapeutics raises Rs 100 Cr in Series A ...
Jul 10, 2024 Immuneel Therapeutics was founded in 2018 by Biocon founder Kiran Mazumdar-Shaw, Pulitzer Prize winner Siddhartha Mukherjee, and Kush Parker.. The Bengaluru-based …See details»
Reducing the costs of blockbuster gene and cell therapies in
Jan 11, 2024 Biotech startup Immuneel, which has in-licensed CAR-T technology for its phase 2 clinical trial, is also working to reduce costs by point-of-care manufacturing. ... the organization …See details»
Cutting-edge CAR-T cancer therapy is now made in India — at
Mar 21, 2024 Several other Indian companies have launched local CAR-T trials, including Immuneel Therapeutics in Bengaluru, which has licensed technology developed by Spanish …See details»
Immuneel Therapeutics - Contacts, Employees, Board Members
Immuneel Therapeutics is a biotechnology startup that focuses on cell therapy and personalized immunotherapy for patients.See details»
Immuneel Therapeutics starts patient trials for CAR-T cancer …
Jun 21, 2022 Immuneel has exclusive rights to ARI-0001/IMN-003A (a CD-19 CAR-T cell therapy) from Hospital ClÃnic de Barcelona and Institut d’Investigacions Biomèdiques August …See details»
Cancer drugs maker Immuneel Therapeutics raises Rs.100-Cr from …
Private Equity Other Private Equity/Strategic Investments. Cancer drugs maker Immuneel Therapeutics raises Rs.100-Cr from UAE pharma co. Entrackr YourStory . Bengaluru-based …See details»
Science - Immuneel Therapeutics Private Limited
Immuneel is committed to continue its development efforts into next generation cellular immunotherapy platforms and technologies aimed at various cancers and other rare diseases. …See details»
Immuneel brings affordable CAR-T therapy to Indian shores - The …
Sep 20, 2019 Biotech veteran Kiran Mazumdar-Shaw, oncologist Siddhartha Mukherjee, and Boston VC Kush Parmar team up to found Immuneel to bring cell therapy to cancer patients in …See details»